RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Everett, WA · +41 more sites
3 recruiting migraine studies with a site in Everett, WA.
Sponsor: AbbVie
Everett, WA · +41 more sites
Sponsor: Pfizer
Bellevue, WA · Everett, WA · Seattle, WA · +166 more sites
Sponsor: AbbVie
Everett, WA · Tacoma, WA · +123 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.